VMBIP Newsletter – July 18, 2008
Please scroll past the charts for VMBIP updates.
McKesson Performance Dashboard 
CDC Weekly Performance Metric Scorecard

A.
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending June 27, 2008:  88.0 percent
Week Ending July 4, 2008:  86.4 percent
Week Ending July 11, 2008:  91.0 percent
Weighted Average Last 3 Weeks:  88.6 percent
Explanation:  None

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders
Week Ending June 27, 2008:  97.1 percent
Week Ending July 4, 2008:  97 percent
Week Ending July 11, 2008:  98.8 percent
Weighted Average Last 3 Weeks:  98.0 percent
Explanation:  none

C1
Metric: 99 percent Order Quality (McKesson Responsibility)
Week Ending June 27, 2008: 99.90 percent  
Week Ending July 4, 2008: 100 percent
Week Ending July 11, 2008:  100 percent
Weighted Average Last 3 Weeks:  99.95 percent 
Explanation:  none

C2
Metric: 99 percent Order Quality (All Responsibility – all error types)
Week Ending June 27, 2008:  98.7 percent
Week Ending July 4, 2008:  98.75 percent
Week Ending July 11, 2008:  99.95 percent
Weighted Average Last 3 Weeks:  99.15 percent
Explanation:  none

D
Metric: 99.75 percent – Cold Chain Quality
Week Ending June 27, 2008:  99.93 percent
Week Ending July 4, 2008:  100 percent
Week Ending July 11, 2008:  100 percent
Weighted Average Last 3 Weeks:  99.97 percent
Explanation:  none

E
Metric: Vaccine Receipt and Put Away and CDC Transmission
Week Ending June 27, 2008:  100 percent
Week Ending July 4, 2008:  100 percent
Week Ending July 11, 2008:  100 percent
Weighted Average Last 3 Weeks:  100 percent
Explanation:  None

F
Metric: State Funded PO Transmission
Week Ending June 27, 2008:  100 percent
Week Ending July 4, 2008:  100 percent
Week Ending July 11, 2008:  100 percent
Weighted Average Last 3 Weeks:  100 percent
Explanation:  None.

A.   percent of provider orders shipped within 3 days of McKesson receiving order from CDC; removes all orders which include an allocated vaccine, and all lines of product on backorder  - an order is defined as all vaccines requested by a provider on a given day; a line (order line) is defined as the individual vaccines that make up the order		 
B.    percent of provider orders shipped within 5 days of McKesson receiving order from CDC; removes all orders which include an allocated vaccine, and all lines of product on backorder	
C1.   percent of provider orders delivered with viable vaccine; excludes errors that aren't McKesson's responsibility – Return Reasons: Temp Monitor, non-compliant pack-out, mis-ship, undeliverable or customer not available, or carrier damage
C2.    percent of provider orders delivered with viable vaccine; includes all errors for both CDC and McKesson: Return Reasons: see C1 for McKesson responsibility reasons and incorrect address and delivery info, site damaged, expired product, product recall, and other are CDC’s responsibility 
D.    percent of provider orders delivered with cold chain maintained – Return Reason: Temp Monitor	
E.    percent of CDC replenishment orders McKesson receives into inventory, receives into IT system, and transmits to CDC within 24 (flu) and 48 (other) hrs of delivery by manufacturer
F.    percent of grantee replenishment orders McKesson faxes and e-mails receipt of to grantees within 48 hrs of delivery by manufacturer

Vaccines on Allocation DTAP-HIB, HEPB-HIB, HIB (TriHIBit, PedvaxHIB and ActHIB) and FLU;  Manufacture Shortage (Merck Hep A)
Vaccines placed on backorder during the most recent week: Hep A (10 doses) – vaccine ordered, waiting on delivery from manufacturer; Hep AB (22,965 doses) - vaccine ordered, waiting on delivery from manufacturer; Hep B – Adult (605 doses) vaccine ordered, waiting on delivery from manufacturer;  Td (7855 doses) - vaccine ordered, waiting on delivery from manufacturer; DTAP, DTAPHBIP, Hep A, Hep A-Adult, Hep B – Adult, Hep B-PF, TD, and TDAP (33,840 dose) – incorrectly identified as a backorder due to systems error, which has been corrected 

McKesson Performance Dashboard – Shipping Metrics by Distribution Center
CDC Weekly Performance Metric Scorecard

Memphis (8578)
A
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending June 27, 2008:  84.7 percent
Week Ending July 4, 2008:  86.7 percent
Week Ending July 11, 2008:  88.6 percent
Weighted Average Last 3 Weeks:  86.5 percent
Explanation:  none

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders
Week Ending June 27, 2008:  96.2 percent
Week Ending July 4, 2008: 95.4 percent
Week Ending July 11, 2008:  99.9 percent
Weighted Average Last 3 Weeks:  97.3 percent
Explanation:  none

Sacramento (8576)
A
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending June 27, 2008:  98.1 percent
Week Ending July 4, 2008: 85.7 percent
Week Ending July 11, 2008:  93.8 percent
Weighted Average Last 3 Weeks:  97.5 percent
Explanation:  none

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders
Week Ending June 27, 2008:  99.9 percent  
Week Ending July 4, 2008:  99.6 percent
Week Ending July 11, 2008:  99.7 percent
Weighted Average Last 3 Weeks: 99.5 percent
Explanation:  none
 
A.   percent of provider orders shipped within 3 days of McKesson receiving order from CDC; removes all orders which include an allocated vaccine, and all lines of product on backorder – an order is defined as all vaccines requested by a provider on a given day; a line (order line) is defined as the individual vaccines that make up the order
B.   percent of provider orders shipped within 5 days of McKesson receiving order from CDC; removes all orders which include an allocated vaccine, and all lines of product on backorder

VMBIP Updates
*VTrckS Web Page
We are happy to announce that the Vaccine Tracking System (VTrckS) web page is established and is located on the Vaccine Management Business Improvement Project (VMBIP) web site at http://www.cdc.gov/vaccines/programs/vmbip/vtrcks.htm.  

*Grantee Advisory Committee Established
In July, a VTrckS Grantee Advisory Committee (GAC) was established. The mission of the GAC is to ensure immunization program needs, as defined in the original requirements, are well represented during all phases of development until VTrckS goes live.  Committee members will perform reviews and provide recommendations to CDC on end-state deliverables, such as detailed business process and/or visual related deliverables.  In addition, the members will:
4	Represent users in identifying current or future procedures; keep the project abreast of the grantees’ IT initiatives and assist with future IIS surveys. The GAC will seek provider input and feedback and report VTrckS progress to grantees.
4	Agree on a formal approach for systematically getting input from and representing other grantees that are not on the Committee.
4	Make recommendations to establish, change, or delete project specifics or issues and develop recommendations to address issues, risks, and constraints when identified. 
Committee member names and individual contact information will be posted to this website soon. 
As a reminder, VMBIP related all-grantee messages are posted to the VMBIP website at: http//www.cdc.gov/vaccines/programs/vmbip/documents.htm and previous newsletters are posted at http//www.cdc.gov/vaccines/programs/vmbip/newsletters.htm 

If you have any questions or comments about the contents of this email, please contact Brad Prescott bap3@cdc.gov or Julie Orta jio7@cdc.gov, with a cc to your project officer. 

Brad Prescott
Project Lead
Vaccine Management Business Improvement Project 
Immunization Services Division 
Centers for Disease Control and Prevention
404-639-8796 (direct)
404-639-8627 (fax)
bap3@cdc.gov

This document can be found on the CDC website at:
http://www.cdc.gov/vaccines/programs/vmbip/downloads/newsletters/vmbip-nl-07-18-08.rtf